Trial Profile
A Phase 2, Two-Part Study of the Safety and Tolerability of Diannexin in Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2014
Price :
$35
*
At a glance
- Drugs Dianexin (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Alavita Pharmaceuticals
- 13 Nov 2014 New trial record